GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $51.99 $51.99 Friday, 27th Jan 2023 CCXI stock ended at $51.99. During the day the stock fluctuated 0% from a day low at $51.99 to a day high of $51.99.
90 days $51.99 $51.99
52 weeks $14.95 $52.00

Historical ChemoCentryx prices

Date Open High Low Close Volume
2022-04-11 $22.70 $22.90 $21.79 $21.94 756 542
2022-04-08 $23.71 $23.92 $22.75 $22.91 891 800
2022-04-07 $24.17 $24.78 $23.36 $23.81 1 494 200
2022-04-06 $24.39 $24.78 $23.86 $24.20 3 054 000
2022-04-05 $26.25 $26.29 $24.70 $24.74 755 300
2022-04-04 $26.86 $27.03 $25.64 $26.27 1 358 300
2022-04-01 $25.32 $26.77 $25.02 $26.71 876 542
2022-03-31 $25.13 $25.60 $24.89 $25.07 477 186
2022-03-30 $25.62 $26.43 $24.83 $25.01 516 692
2022-03-29 $24.51 $25.87 $24.34 $25.71 1 016 600
2022-03-28 $24.14 $24.68 $23.55 $24.33 549 800
2022-03-25 $24.30 $24.30 $23.28 $23.96 630 200
2022-03-24 $23.97 $24.65 $23.54 $24.45 462 800
2022-03-23 $24.65 $25.15 $23.80 $23.86 645 400
2022-03-22 $24.27 $25.00 $24.25 $24.96 599 629
2022-03-21 $25.53 $25.62 $24.06 $24.31 601 354
2022-03-18 $25.07 $25.97 $24.82 $25.56 1 798 020
2022-03-17 $24.17 $25.29 $23.63 $25.25 1 003 700
2022-03-16 $23.13 $24.19 $22.93 $24.17 877 800
2022-03-15 $22.26 $23.26 $22.11 $22.91 805 700
2022-03-14 $23.73 $24.17 $21.77 $22.22 1 598 500
2022-03-11 $25.00 $25.55 $23.70 $23.72 799 500
2022-03-10 $24.92 $24.96 $23.58 $24.85 785 100
2022-03-09 $24.42 $25.88 $24.42 $25.21 1 144 000
2022-03-08 $23.28 $24.52 $22.61 $24.15 1 229 900
Click to get the best stock tips daily for free!

About ChemoCentryx

ChemoCentryx ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT